RBR-10gm45rdNot yet recruitingUnknown
ORC_95616_EN23-0748-01_Assessment of primary dermal irritability, cumulative dermal irritability, and dermal sensitization (HRIPT) - HRIPT Human Repeat Insult Patch Test
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18Y to 70Y (—)
Inclusion Criteria
- •Participants of both sexes aged 18 to 70; phototype: I, II, III and IV; skin in the application region is complete; agreement to follow the trial procedures and attend the clinic on the specified days and times; understanding, consent and signature of the free and informed consent form
Exclusion Criteria
- •Pregnancy or risk of pregnancy and/or lactation; use of anti-inflammatory drugs 30 days and/or immunosuppressants for up to three months before selection; immunosuppression by drugs or active diseases; decompensated endocrinopathies; personal history of atopy; intense sun exposure or tanning sessions up to 15 days before the assessment or during the study period; expect intense exposure to sunlight or tanning sessions during the study period; provision for bathing in the sea, swimming pool or sauna during the study; practice of water sports during the study; dermographism; use of oral or topical treatment with vitamin A acid and/or its derivatives up to 1 week before the start of the study; aesthetic and/or dermatological treatment on the body within 03 weeks before selection; vaccination scheduled during the study period or up to 3 weeks before selection; history of sensitization, irritation or photosensitization to topical products; active skin pathologies that may interfere with the study results; skin reactivity; use of new medications/cosmetics during the study; previous participation in studies with the same product; congenital or acquired immunodeficiency; relevant medical history or current evidence of alcohol or other drug abuse; known or suspected history of intolerance to any ingredient of the study product; history of lack of adherence or unwillingness to adhere to the study protocol; employees of Medcin or the sponsoring company involved in the study, or an immediate family member of an employee involved in the study
Investigators
Similar Trials
Terminated
Phase 1
Sensitization Potential Evaluation - BARZILAIDisturbances of skin sensationL00-L99RBR-8sv755INFAN - Indústria Química e Farmacêutica Nacional
Active, not recruiting
Not Applicable
Assessment of skin irritability.Wounds and injuriesEstheticsF02.463.785.477RBR-6hnmxvIpclin - Pesquisa Clínica Integrada
Not yet recruiting
Unknown
Assessment of skin irritability after using a health product responsible for reinforcing the skin's protection barrier, preventing microorganisms that cause skin diseasesAccidental InjuryNon-penetrating WoundsPenetrating WoundsDermatopathiesRBR-7jc7btrMedicin Instituto da Pele Ltda
Not yet recruiting
Not Applicable
Health Product Irritability and Sensitization Assessment through Contact TestArtificial toothE06.780.346.875RBR-587ptdIpclin - Pesquisa Clínica Integrada
Not yet recruiting
Not Applicable
Assessment of skin irritabilityBurnsCold InjurylacerationsRBR-5qyszr9Medicin Instituto da Pele Ltda